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nfl uenza vaccination is a common annual event among individuals in the United States. Complications, although infrequent, are usually mild and self-limiting. Following immunization, localized swelling, erythema, and pain in and around the injection site can occur and generally resolves in 1 to 2 days. 1 Shoulder pain progressing to the point of limited range of motion (ROM) and dysfunction following infl uenza vaccination have been reported and resolved with subacromial injection and physical therapy. 2 This article describes the fi rst reported case of progressive osteolysis and surface chondrolysis of the proximal humerus following routine infl uenza vaccination that required surgical intervention.
CASE REPORT
A 46-year-old man presented with left shoulder pain of 3 weeks' duration, which started immediately following an infl uenza vaccination in the left deltoid area. He reported no recent trauma, and the left shoulder had been asymptomatic preceding the vaccination, including a complete recovery from an open Bankart repair performed 13 years previously. The patient was healthy, with no medical comorbidities, and reported no previous corticosteroid use or alcohol abuse.
The vaccination was given with a 1-inch needle and placed into the left deltoid muscle in a lateral and proximal position, approximately 2 cm distal to the lateral aspect of the acromion. No immediate vaccination complications or infectious changes of the skin occurred. Left shoulder discomfort began a few days following the injection, progressively worsened, and partially subsided with nonsteroidal anti-infl ammatory drugs (NSAIDs). The pain was localized to the anterior shoulder joint and was exacerbated with overhead activities.
Initial examination demonstrated a healthy-appearing man with no excessive muscle mass or subcutaneous fat surrounding the shoulder girdle. No changes of the skin were noted. Forward fl exion (150), external rotation (35°), and internal rotation (L2) were limited compared with the unaffected side (160°, 45°, T7, respectively). He had tenderness over the biceps tendon and deltoid laterally. O'Brien's and Speed's tests were positive. Plain radiographs revealed a small lytic area involving the greater tuberosity of the humeral head and surgical changes relating to Bankart repair ( Figure 1A ). Magnetic resonance imaging (MRI) revealed abnormal uptake and cystic changes involving the greater tuberosity of the humeral head ( Figure 1B) . No bone marrow changes occurred, consistent with early osteonecrosis of the humeral head ( Figure 1B ). Bone scan revealed isolated increased signal intensity involving the lateral aspect of the humeral head.
Conservative management over the next 5 months, including NSAIDs and occupational therapy, was unsuccessful. No cortisone injections were administered. The patient's left shoulder pain and disability worsened, and he was unable to return to normal activities of daily living. Follow-up revealed continued tenderness over the biceps tendon and further limitation on internal rotation to L5. Laboratory results, including white blood cell count, C-reactive protein, and erythrocyte sedimentation rate, were normal. Repeat MRI of the left shoulder revealed progression of the cystic changes and abnormal signal uptake involving the greater tuberosity of the humeral head ( Figure 2 ). The patient's clinical dysfunction was worsening, and the greater tuberosity cyst was rapidly enlarging despite conservative measures. Surgical intervention was recommended. The patient underwent diagnostic arthroscopy of the shoulder and open biopsy of the cystic area involving the greater tuberosity. Arthroscopy revealed a hyperemic joint capsule and extensive chondrolysis involving approximately 50% of the articular surface of the humeral head with a central, fullthickness defect. Hyperemia of the exposed subchondral bone was noted. The glenoid demonstrated minimal chondral fraying. The biceps tendon was intact but hyperemic and consistent with tenosynovitis. No intra-articular interventions were performed during this initial surgical procedure except thorough arthroscopic irri- 
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gation. During open biopsy of the humeral greater tuberosity, the lateral cortex was softened, and when opened, a serosanguinous fl uid exited. The area was thoroughly debrided, and bone grafting was initially delayed due to concern for possible infection because the intraoperative frozen section was inconclusive. The cultures obtained intraoperatively were negative for infection and showed no histological evidence of osteonecrosis. Pathological examination of surgical specimens demonstrated infl ammatory cells and granulation tissue, consistent with reactive disease or foreign-body response ( Figure 3A ). The progressive humeral lesion and infl ammatory component was attributed to a reaction following the infl uenza vaccination, most likely given intraosseously. In addition, the extensive humeral head chondrolysis and biceps tendonitis were likely an infl ammatory reaction to the injection and contributed to the patient's dysfunction and pain. Therefore, the patient underwent resurfacing of the proximal humerus and biceps tenodesis. Full-thickness chondral defects were observed before resurfacing ( Figure 3B ). Bone grafting of the greater tuberosity was not undertaken because the defect would probably resolve with time following the initial debridement.
Postoperatively, the patient completed additional physical therapy and was weaned off all narcotics and NSAIDs. At most recent follow-up Ͼ3 years postoperatively, the patient had pain-free ROM of the left shoulder and excellent alignment ( Figure 4) , and had returned to all activities.
DISCUSSION
Illness from the infl uenza virus commonly results in self-limited myalgias, fevers, and respiratory problems, but more serious cases have resulted in Ͼ200,000 hospitalizations and 36,000 deaths each year in the United States. 3 Young and elderly individuals and those with comorbid conditions that may result in an immunocompromised state are at the highest risk for developing serious complications from infl uenza infection. 3 Therefore, thousands of individuals receive an annual infl uenza vaccination as an important preventative medical intervention, including Ͼ50% of individuals older than 65 years. 2 Complications following infl uenza vaccination are infrequent and tend to be mild and self-limiting. The actual frequency of postvaccination side effects is not known, but they include low-grade fever, localized discomfort, swelling, and erythema. 1 To the best of our knowledge, we present the fi rst reported case of progressive osteolysis and reactive chondrolysis following infl uenza immunization. Intraarticular and intraosseous vaccination placement is thought to be the reason for the observed fi ndings. Currently, no medical or surgical interventions are described for this problem. In our case, an operative approach was undertaken after all conservative measures were exhausted. The area of lateral humeral head osteolysis was treated with thorough debridement and irrigation. The extensive humeral head chondrolysis and biceps tendonitis were addressed with prosthetic humeral head resurfacing and biceps tenodesis. Postoperative rehabilitation with physical therapy guidance was essential to complete resolution of all symptoms.
When progressive proximal humerus osteolysis is demonstrated on serial radiographs, the differential diagnosis may include but is not limited to several genetically based or idiopathic diseases second- ary to inoculation of a foreign substance. Genetic and idiopathic syndromes may include Farber's disease, idiopathic multicentric osteolysis (carpal-tarsal osteolysis), Winchester's syndrome, and neurogenic osteolysis. 4, 5 In addition, Gorham's disease must be considered in the differential when osteolytic changes are present in the proximal humerus. Proliferation of vascular fi brous tissue with resultant bone resorption characterizes this rare disease and may cause massive osteolysis. 4 A thorough patient history, observation period, and sequential imaging help to exclude Gorham's disease, whose treatment may include bisphosphonates, radiation therapy, interferons, and surgical intervention. 4 Our patient had no underlying genetic disorder, and his shoulder dysfunction and radiographic evidence of osteolysis coincided with the infl uenza immunization.
Chondrolysis of the glenohumeral joint is a condition in which chondrocyte death follows exposure to a toxic substance, which rarely occurs during arthroscopic shoulder procedures. 6, 7 The true etiology of chondrocyte death following arthroscopy is not fully understood, but may include thermal damage, prominent implants, or intra-articular pain pump infusions. 6, 8 Patients with symptomatic glenohumeral chondrolysis following shoulder arthroscopy typically return to the orthopedist 6 to 24 months following the index procedure and report shoulder pain, limited ROM, and shoulder dysfunction. [6] [7] [8] In published series, postoperative radiographs reveal rapid, progressive loss of the glenohumeral joint. 6, 7 In addition, MRI may reveal subchondral marrow edema and sclerosis, which typically involve the medial border of the humeral head opposing the superior glenoid. 7 If conservative measures fail, prosthetic or biological glenohumeral resurfacing procedures become options. 6 In our case, we were uncertain whether chondrolytic changes of the humeral head were present or established at the initial arthroscopy Ͼ10 years prior to infl uenza immunization. However, the patient's shoulder was asymptomatic and fully functional for Ͼ12 years prior to vaccination and became problematic following vaccination. The infl uenza immunization caused infl ammatory changes in the shoulder joint as confi rmed with arthroscopic visualization and histopathologic examination, which likely induced humeral head chondrolysis or converted an asymptomatic chondrolytic process to a symptomatic shoulder condition with limited ROM and function.
In patients presenting with progressive shoulder pain and dysfunction, osteonecrosis of the humeral head must be considered. This disease occurs following injury to the vasculature supplying the humeral head and may cause subchondral bone death, bone collapse, and loss of the humeral head shape with resultant abnormal glenohumeral articulation. 9 Our patient had no history of hemoglobinopathy, connective tissue disorder, alcohol use, corticosteroid use, recent traumatic event, or occupational hazard (Caisson disease), which can all be related to the development of humeral head osteonecrosis. 9, 10 Furthermore, the progressive radiographic changes as described by Cruess 11 were not observed in our patient. Magnetic resonance imaging revealed no subchondral hyperemia, fractures, or collapse.
This case should not discourage individuals from pursuing yearly immunization because it has proven to be a successful intervention combating seasonal infl uenza. 3 However, we report humeral head osteolysis and surface chondrolysis as a potential complication following improper immunization placement. Severe shoulder pain and dysfunction coupled with progressive osteolysis and chondrolysis may require surgical debridement and resurfacing if all conservative measures fail.
